Clinical Trial Update: A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating Dupilumab for sleep disturbance in adults with uncontrolled persistent asthma. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2024-11-26